L-threonine methyl ester hydrochloride

L-threonine methyl ester hydrochloride is an L-configured threonine derivative presented as a methyl ester hydrochloride, combining a chiral α-amino acid framework with an esterified carboxyl group and a protonated amine salt. The molecule contains a β-hydroxyl side chain characteristic of threonine, enabling hydrogen-bonding interactions and selective functional-group transformations, while the methyl ester and amino salt state influence coupling behavior and protection/deprotection compatibility. Esterification converts the carboxyl functionality into a methyl ester that can be activated for peptide coupling or converted into other acyl equivalents, and the hydrochloride form supports handling as a chiral intermediate in synthetic sequences. The stereochemical integrity at the α-carbon and the reactive side-chain hydroxyl make it suitable for controlled derivatization toward peptide building blocks, chiral intermediates, and downstream functionalized amino acid derivatives.

1. Protected Amino Acid Chemistry

L-threonine methyl ester hydrochloride is applied in protected amino acid synthesis workflows where the L-threonine stereocenter and β-hydroxyl group require orthogonal protection planning. The methyl ester can be retained during N-protection steps or transformed into alternative acyl forms, while the amino hydrochloride state facilitates formation of N-protected derivatives under standard peptide-compatible conditions. The β-hydroxyl functionality can be selectively masked with hydroxyl-protecting groups to control chemoselective reactions during subsequent peptide coupling or side-chain modification. Downstream processing can generate threonine building blocks suitable for peptide assembly, chiral intermediate preparation, and stereochemically defined amino acid derivative libraries used in synthetic organic chemistry.

2. Peptide Synthesis

L-threonine methyl ester hydrochloride is suitable for peptide building block preparation and peptide coupling chemistry in solution-phase or solid-phase synthesis strategies. The amino functionality and esterified carboxyl group provide a defined handle for converting the molecule into coupling-ready forms, enabling incorporation of L-threonine residues with controlled side-chain hydroxyl chemistry. The β-hydroxyl group can be protected to prevent side reactions during chain elongation, supporting formation of clean amide linkages while preserving the threonine stereochemistry. Resulting threonine-containing peptide analogs and protected intermediates can be used for sequence-specific studies, peptide material development, and synthetic methodology development in applied peptide science.

3. Side-Chain Functionalization

L-threonine methyl ester hydrochloride supports side-chain functionalization programs that leverage the β-hydroxyl group for derivatization into chemically distinct threonine analogs. The presence of an L-configured amino acid backbone with a reactive hydroxyl enables conversion to ether, ester, or other oxygen-functional derivatives that can modulate polarity and hydrogen-bonding patterns in downstream molecules. The methyl ester and amino salt can be managed through protection and activation strategies so that side-chain transformations proceed with minimal disruption to the chiral center and amino acid functionality. Functionalized threonine derivatives derived from this intermediate can feed into peptidomimetic construction, SAR-focused analog generation, and synthetic routes that require controlled stereochemical presentation of oxygen-containing motifs.

4. Chemical Biology Probes

L-threonine methyl ester hydrochloride is used in chemical biology research for generating chiral amino acid derivatives and peptide-like probes bearing threonine-derived oxygen functionalities. The β-hydroxyl group can serve as a functional handle for installing recognition elements, linkers, or conjugation-ready motifs after appropriate protection and activation steps. The amino acid ester form can be converted into acyl equivalents that participate in labeling workflows or scaffold assembly, while maintaining the L-configuration for stereochemically consistent molecular recognition. Downstream products can be incorporated into biomolecule-modifying reagents, affinity probes, or analytical standards where threonine-specific stereochemistry and hydroxyl functionality influence binding and reactivity.

5. Pharmaceutical Intermediate Preparation

L-threonine methyl ester hydrochloride is relevant to pharmaceutical intermediate preparation and fine chemical synthesis where threonine stereochemistry and oxygen functionality are required in controlled manufacturing routes. The protected amino acid derivative logic enabled by the methyl ester and amino hydrochloride salt supports conversion into N-protected intermediates and activated acyl forms used to build larger fragments. The β-hydroxyl group can be managed to ensure chemoselective transformations during synthesis of peptidic or peptidomimetic intermediates and related chiral scaffolds. Industrially oriented sequences can employ this compound as a chiral starting material for producing threonine-based intermediates that feed into downstream synthesis of functional molecules used across chemical manufacturing and applied development programs.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line